v3.22.2.2
SCHEDULE OF SEGMENT FINANCIAL INFORMATION BY BUSINESS SEGMENT (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Mar. 31, 2022
Cash, cash equivalents, marketable securities and certain restricted cash $ 72,551   $ 72,551   $ 90,230
Total liabilities (18,387)   (18,387)   (20,990)
Non-controlling interests 4,847   4,847   $ 5,505
Net loss for the three months ended September 30, 2022 (11,968) $ (8,692) (22,902) $ (15,435)  
Depreciation, Depletion and Amortization, Nonproduction 112 65 235 123  
Share-Based Payment Arrangement, Noncash Expense 4,714 $ 1,155 9,338 2,371  
Cash used in operations     (16,059) $ (8,898)  
Beyond Air [Member]          
Cash, cash equivalents, marketable securities and certain restricted cash 40,754   40,754    
All other assets 16,406   16,406    
Total liabilities (17,747)   (17,747)    
Net assets – net liabilities 39,413   39,413    
Non-controlling interests      
Net loss for the three months ended September 30, 2022 (8,650)   (16,703)    
Depreciation, Depletion and Amortization, Nonproduction 112   232    
Share-Based Payment Arrangement, Noncash Expense 2,484   4,880    
Cash used in operations (7,123)   (12,635)    
Beyond Cancer [Member]          
Cash, cash equivalents, marketable securities and certain restricted cash 24,291   24,291    
All other assets 588   588    
Total liabilities (640)   (640)    
Net assets – net liabilities 24,239   24,239    
Non-controlling interests 4,847   4,847    
Net loss for the three months ended September 30, 2022 (4,148)   (7,749)    
Depreciation, Depletion and Amortization, Nonproduction 2   4    
Share-Based Payment Arrangement, Noncash Expense 2,231   4,458    
Cash used in operations $ (2,097)   $ (3,425)